Results 281 to 290 of about 9,625,606 (401)

Development of Graves' disease in a patient with lymphocytic hypophysitis following glucocorticoid treatment. [PDF]

open access: yesEndocrinol Diabetes Metab Case Rep
Ono Y   +5 more
europepmc   +1 more source

The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis

open access: yesAdvanced Science, EarlyView.
This review summarizes recent advances in understanding the immune microenvironment's role in fibrosis, focusing on phenotypic/functional alterations of immune cells and their dynamic interactions with other cellular constituents within tissues. The authors further explore therapeutic opportunities and challenges in targeting immune microenvironment ...
Xiangqi Chen   +6 more
wiley   +1 more source

Unilateral Graves' Disease With Ipsilateral Papillary Thyroid Cancer: A Case Report. [PDF]

open access: yesCureus
Alqattan MH   +5 more
europepmc   +1 more source

Changes in serum T3 T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease

open access: bronze, 1977
Hajime TAMA   +7 more
openalex   +2 more sources

A Wearable In‐Pad Diagnostic for the Detection of Disease Biomarkers in Menstruation Blood

open access: yesAdvanced Science, EarlyView.
MenstruAI integrates a paper‐based biosensor into sanitary pads to detect biomarkers in menstrual blood, enabling accessible, lab‐free diagnostics health. The platform supports early disease detection, especially in underserved communities, while challenging menstrual stigma and opening pathways for scalable, inclusive, and sustainable population ...
Lucas Dosnon   +3 more
wiley   +1 more source

Graves' ophthalmopathy

open access: yesSwiss Medical Weekly, 2002
Swiss Medical Weekly
doaj   +1 more source

Liver Dysfunction in a Patient with Graves' Disease. [PDF]

open access: yesJ Clin Med
Campos F   +5 more
europepmc   +1 more source

Antidepressant-related deaths. [PDF]

open access: yes, 2004
Griffiths, C, Morgan, O
core   +1 more source

Translation of a Human‐Based Malaria‐on‐a‐Chip Phenotypic Disease Model for In Vivo Applications

open access: yesAdvanced Science, EarlyView.
Inoculation of the Malaria‐on‐a‐Chip model with human erythrocytes infected with Plasmodium falciparum can support the entire intraerythrocytic lifecycle for 7 days in vitro. Utilizing this human‐based, serum‐free model provides an alternative to animal testing by introducing a human‐based, preclinical alternative for antimalarial therapeutic delivery.
Michael J. Rupar   +15 more
wiley   +1 more source

Evaluating the technetium-99 m pertechnetate flow protocol for Graves' disease: methodological insights: a case series. [PDF]

open access: yesJ Med Case Rep
Asiri JA   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy